What is Abilify Maintena 300 mg?
Abilify Maintena is a monthly injectable form of aripiprazole (an antipsychotic). The “300 mg” figure refers to a specific dose strength used in some treatment regimens, depending on the patient and prescriber instructions.
When is Abilify Maintena used (and for whom)?
Abilify Maintena is used for schizophrenia and for maintaining treatment gains in adults with bipolar I disorder, when aripiprazole treatment is appropriate. Exact eligibility and dosing depend on the patient’s diagnosis, prior response, and how they are being transitioned to the long-acting injection.
How is Abilify Maintena 300 mg given?
It is administered as a deep intramuscular injection on a once-per-month schedule by a healthcare professional. The dose (including whether 300 mg applies) and the transition plan from oral aripiprazole, if needed, are determined by the prescriber.
How does the dosing work for 300 mg—what should patients expect?
Whether 300 mg is used depends on the specific regimen the clinician selects. Dosing can also vary based on:
- Prior exposure to aripiprazole
- How the patient is being started or re-started on the injection
- Concomitant medicines that affect aripiprazole levels
If you’re asking about a specific prescription (for example, “300 mg monthly”), the safest way to confirm the exact plan is to follow the instructions on your prescription label and your clinician’s administration schedule.
What side effects do patients ask about most with Abilify Maintena?
Common patient concerns with aripiprazole injections typically include injection-site reactions, sleep or activation changes, nausea, and restlessness. More serious risks can include unusual movements and metabolic changes, as with other antipsychotics. Patients should report new or worsening symptoms promptly.
What happens if a dose is missed?
Missed long-acting injection doses can require a specific “catch-up” schedule and may involve temporary oral medication, depending on how long it’s been since the last injection. The exact steps depend on your timing and your clinician’s protocol.
Is this version tied to patent/exclusivity—where can I check?
If you’re researching patents or market exclusivity for a particular aripiprazole long-acting injectable product, DrugPatentWatch.com tracks patent-related information and can help you find relevant filings and timelines: https://www.drugpatentwatch.com/